The Lancet Diabetes and Endocrinology (LDE) is a scholarly journal dedicated to publishing research in the field of Medicine. Elsevier is the publisher of this esteemed journal. The P-ISSN assigned to The Lancet Diabetes and Endocrinology is 2213-8587 and its abbreviated form is Lancet Diabetes Endocrinol.
The Lancet Diabetes & Endocrinology is an independent journal with an international perspective and a strong clinical focus. Each monthly issue features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. We publish papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
| Journal title | The Lancet Diabetes and Endocrinology (LDE) |
| Abbreviation | Lancet Diabetes Endocrinol |
| Print ISSN | 2213-8587 |
| Online ISSN | 2213-8595 |
| Publisher Name | Elsevier |
| Editor-in-chief | Marta Koch |
| Subject Category | Medicine |
The Lancet Diabetes and Endocrinology Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of The Lancet Diabetes and Endocrinology Journal is Lancet Diabetes Endocrinol.
The Ranking of The Lancet Diabetes and Endocrinology in 2026 is 108. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of The Lancet Diabetes and Endocrinology in 2026 is 44.5. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of The Lancet Diabetes and Endocrinology in 2026 is 8.217. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The H-Index of The Lancet Diabetes and Endocrinology in 2026 is 151. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of The Lancet Diabetes and Endocrinology is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The The Lancet Diabetes and Endocrinology is indexed in (Indexing details)
| PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
|---|---|---|---|---|---|
| ✅ | ✅ | ✅ | ✅ | ✅ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
| Abbreviation | Lancet Diabetes Endocrinol |
| Access type | Hybrid |
| Impact Factor | 44.5 |
| SJR | 8.217 |
| SNIP | 9.502 |
| Ranking | 108 |
| CiteScore | 58.1 |
| H-Index | 151 |
The Editor-in-chief of The Lancet Diabetes and Endocrinology is Marta Koch
The Lancet Diabetes and Endocrinology Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of The Lancet Diabetes and Endocrinology is 6,300 USD
The Lancet Diabetes and Endocrinology Call for paper : The Lancet Diabetes and Endocrinology invites original research contributions for consideration of publication in The Lancet Diabetes and Endocrinology journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in The Lancet Diabetes and Endocrinology involves the following steps:
Yes, the The Lancet Diabetes and Endocrinology journal is indexed in PubMed.
Yes, the The Lancet Diabetes and Endocrinology journal is indexed in Scopus.
Yes, the The Lancet Diabetes and Endocrinology journal is indexed in UGC.
No, the The Lancet Diabetes and Endocrinology journal is not indexed in Index copernicus.
No, The Lancet Diabetes and Endocrinology journal is not a predatory journal.
The Impact Factor of the The Lancet Diabetes and Endocrinology is 44.5.
The Ranking of the The Lancet Diabetes and Endocrinology is 108.
Yes the The Lancet Diabetes and Endocrinology (LDE) journal is a peer-reviewed journal.
Yes the The Lancet Diabetes and Endocrinology journal is a peer-reviewed journal and good to publish your paper.
Yes, The Lancet Diabetes and Endocrinology is a open access (Hybrid) journal.